Total Payments
$16,641
2024 Payments
$3,375
Companies
63
Transactions
747
Medicare Patients
10,218
Medicare Billing
$1.8M
Payment Breakdown by Category
Food & Beverage$14,217 (85.4%)
Travel$2,150 (12.9%)
Education$259.01 (1.6%)
Other$14.56 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $14,217 | 732 | 85.4% |
| Travel and Lodging | $2,150 | 10 | 12.9% |
| Education | $259.01 | 4 | 1.6% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $14.56 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boston Scientific Corporation | $4,573 | 125 | $0 (2024) |
| Medtronic USA, Inc. | $3,438 | 68 | $0 (2020) |
| BIOTRONIK NRO, Inc. | $1,301 | 23 | $0 (2024) |
| ABBVIE INC. | $934.93 | 49 | $0 (2024) |
| Averitas Pharma Inc. | $583.21 | 24 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $514.25 | 27 | $0 (2024) |
| Collegium Pharmaceutical, Inc. | $436.65 | 24 | $0 (2024) |
| Lundbeck LLC | $417.34 | 15 | $0 (2024) |
| Daiichi Sankyo Inc. | $366.09 | 19 | $0 (2019) |
| Assertio Therapeutics, Inc. | $298.86 | 37 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,375 | 106 | BIOTRONIK NRO, Inc. ($984.55) |
| 2023 | $1,938 | 83 | AbbVie Inc. ($426.85) |
| 2022 | $625.74 | 37 | ABBVIE INC. ($209.60) |
| 2021 | $700.82 | 12 | BOSTON SCIENTIFIC CORPORATION ($656.13) |
| 2020 | $390.94 | 16 | Medtronic USA, Inc. ($204.42) |
| 2019 | $2,792 | 165 | Boston Scientific Corporation ($1,190) |
| 2018 | $4,486 | 203 | Medtronic USA, Inc. ($2,138) |
| 2017 | $2,333 | 125 | BOSTON SCIENTIFIC CORPORATION ($652.87) |
All Payment Transactions
747 individual payment records from CMS Open Payments — Page 1 of 30
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $15.15 | General |
| Category: Neurology | ||||||
| 12/13/2024 | Averitas Pharma Inc. | QUTENZA (Drug) | Food and Beverage | In-kind items and services | $37.29 | General |
| Category: PAIN MANAGEMENT | ||||||
| 12/13/2024 | Boston Scientific Corporation | WaveWriter Alpha Prime 16 (Device) | Food and Beverage | In-kind items and services | $20.84 | General |
| Category: WaveWriter Alpha_NMD | ||||||
| 12/05/2024 | Neurelis, Inc. | VALTOCO (Drug) | Food and Beverage | In-kind items and services | $14.74 | General |
| Category: EPILEPSY | ||||||
| 12/03/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $28.26 | General |
| Category: NEUROLOGY | ||||||
| 11/27/2024 | Averitas Pharma Inc. | QUTENZA (Drug) | Food and Beverage | In-kind items and services | $32.20 | General |
| Category: PAIN MANAGEMENT | ||||||
| 11/25/2024 | ABBVIE INC. | BOTOX (Biological), QULIPTA | Food and Beverage | In-kind items and services | $19.36 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/20/2024 | Averitas Pharma Inc. | QUTENZA (Drug) | Food and Beverage | In-kind items and services | $35.42 | General |
| Category: PAIN MANAGEMENT | ||||||
| 11/20/2024 | Boston Scientific Corporation | WaveWriter Alpha Prime 16 (Device) | Food and Beverage | In-kind items and services | $8.80 | General |
| Category: WaveWriter Alpha_NMD | ||||||
| 11/14/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $18.11 | General |
| Category: Neurology | ||||||
| 11/14/2024 | Teva Pharmaceuticals USA, Inc. | AJOVY (Biological) | Food and Beverage | In-kind items and services | $14.79 | General |
| Category: Central Nervous System | ||||||
| 11/12/2024 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $14.19 | General |
| Category: Neuroscience | ||||||
| 11/05/2024 | Lilly USA, LLC | AMYVID (Drug), KISUNLA | Food and Beverage | In-kind items and services | $13.53 | General |
| Category: Neuroscience | ||||||
| 11/04/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $24.44 | General |
| Category: Opioid Analgesic | ||||||
| 11/01/2024 | Merz Pharmaceuticals, LLC | Xeomin (Biological) | Food and Beverage | In-kind items and services | $20.74 | General |
| Category: Musculoskeletal | ||||||
| 10/29/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $17.68 | General |
| Category: Central Nervous System | ||||||
| 10/28/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $24.00 | General |
| Category: NEUROSCIENCE | ||||||
| 10/23/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $30.47 | General |
| Category: NEUROLOGY | ||||||
| 10/15/2024 | BIOTRONIK NRO, Inc. | Prospera (Device) | Food and Beverage | In-kind items and services | $26.41 | General |
| Category: Not Applicable | ||||||
| 10/11/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $40.34 | General |
| 10/08/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $17.23 | General |
| Category: Opioid Analgesic | ||||||
| 10/03/2024 | ABBVIE INC. | BOTOX (Biological), QULIPTA | Food and Beverage | In-kind items and services | $20.34 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 09/30/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $22.84 | General |
| Category: Neuropsychiatry | ||||||
| 09/27/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $16.73 | General |
| Category: NEUROSCIENCE | ||||||
| 09/27/2024 | Teva Pharmaceuticals USA, Inc. | AJOVY (Biological) | Food and Beverage | In-kind items and services | $14.98 | General |
| Category: Central Nervous System | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 35 | 2,168 | 5,376 | $1.8M | $436,453 |
| 2022 | 41 | 2,542 | 7,376 | $2.3M | $554,034 |
| 2021 | 39 | 2,870 | 9,912 | $2.4M | $399,359 |
| 2020 | 37 | 2,638 | 8,358 | $2.3M | $363,386 |
Total Patients
10,218
Total Services
31,022
Medicare Billing
$1.8M
Procedure Codes
152
All Medicare Procedures & Services
152 procedure records from CMS Medicare Utilization — Page 1 of 7
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J7999 | Compounded drug, not otherwise classified | Office | 2023 | 12 | 44 | $286,750 | $158,610 | 55.3% |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Office | 2023 | 98 | 145 | $181,540 | $34,004 | 18.7% |
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2023 | 89 | 89 | $32,964 | $21,304 | 64.6% |
| 27096 | Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | Office | 2023 | 101 | 126 | $60,071 | $20,548 | 34.2% |
| 64635 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | Office | 2023 | 36 | 44 | $88,000 | $20,111 | 22.9% |
| 64490 | Injection of upper or middle spine facet joint using imaging guidance, single level | Office | 2023 | 52 | 86 | $80,754 | $16,904 | 20.9% |
| 64633 | Destruction of upper or middle spinal facet joint nerves using imaging guidance, single facet joint | Office | 2023 | 25 | 31 | $63,178 | $13,602 | 21.5% |
| 76942 | Ultrasonic guidance for needle placement | Office | 2023 | 141 | 311 | $186,600 | $13,565 | 7.3% |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | Office | 2023 | 45 | 68 | $63,852 | $12,599 | 19.7% |
| 64450 | Injection of anesthetic agent and/or steroid into other nerve or branch | Office | 2023 | 53 | 299 | $141,169 | $11,072 | 7.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 86 | 86 | $32,680 | $10,088 | 30.9% |
| 62321 | Injection of substance into middle or upper spine canal using imaging guidance | Office | 2023 | 37 | 55 | $86,790 | $9,906 | 11.4% |
| 20611 | Aspiration and/or injection of fluid large joint using ultrasound guidance | Office | 2023 | 99 | 135 | $41,310 | $9,880 | 23.9% |
| 64636 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | Office | 2023 | 31 | 36 | $27,576 | $8,980 | 32.6% |
| 64491 | Injection of upper or middle spine facet joint using imaging guidance, second level | Office | 2023 | 51 | 85 | $60,544 | $8,737 | 14.4% |
| 20606 | Aspiration and/or injection of fluid from medium joint using ultrasound guidance | Office | 2023 | 83 | 103 | $30,591 | $8,417 | 27.5% |
| 64634 | Destruction of upper or middle spinal facet joint nerves using imaging guidance, each additional facet joint | Office | 2023 | 23 | 26 | $22,230 | $6,924 | 31.1% |
| 64494 | Injection of lower or sacral spine facet joint using imaging guidance, second level | Office | 2023 | 43 | 65 | $36,102 | $6,550 | 18.1% |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | Office | 2023 | 263 | 1,055 | $15,825 | $5,348 | 33.8% |
| 64400 | Injection of anesthetic agent and/or steroid into face nerve | Office | 2023 | 28 | 65 | $43,225 | $5,067 | 11.7% |
| 64405 | Injection of anesthetic agent and/or steroid into upper neck and back of head nerve | Office | 2023 | 52 | 66 | $30,954 | $4,875 | 15.7% |
| 64484 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | Office | 2023 | 37 | 52 | $34,580 | $4,425 | 12.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 63 | 120 | $10,800 | $4,308 | 39.9% |
| 64418 | Injection of anesthetic agent and/or steroid into suprascapular shoulder nerve | Office | 2023 | 48 | 60 | $56,340 | $3,926 | 7.0% |
| 95991 | Maintenance of spinal canal or brain drug infusion pump by health care professional | Office | 2023 | 12 | 45 | $15,750 | $3,579 | 22.7% |
About Dr. Paul Carnes, M.D
Dr. Paul Carnes, M.D is a Anesthesiology healthcare provider based in Raleigh, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/30/2005. The National Provider Identifier (NPI) number assigned to this provider is 1417940990.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Paul Carnes, M.D has received a total of $16,641 in payments from pharmaceutical and medical device companies, with $3,375 received in 2024. These payments were reported across 747 transactions from 63 companies. The most common payment nature is "Food and Beverage" ($14,217).
As a Medicare-enrolled provider, Carnes has provided services to 10,218 Medicare beneficiaries, totaling 31,022 services with total Medicare billing of $1.8M. Data is available for 4 years (2020–2023), covering 152 distinct procedure/service records.
Ad
Practice Information
- Specialty Anesthesiology
- Other Specialties Anesthesiology, Pain Medicine
- Location Raleigh, NC
- Active Since 08/30/2005
- Last Updated 04/01/2021
- Taxonomy Code 207L00000X
- Entity Type Individual
- NPI Number 1417940990
Products in Payments
- SPECTRA WAVEWRITER (Device) $2,129
- INTELLIS (Device) $1,198
- SYNCHROMED (Device) $1,018
- Prospera (Device) $984.55
- GENERAL PAIN MANAGEMENT (Device) $615.36
- QUTENZA (Drug) $583.21
- BOTOX (Biological) $494.77
- ADAPTIVESTIM (Device) $489.61
- VYEPTI (Biological) $396.40
- GENERAL - PAIN MANAGEMENT (Device) $337.45
- ACTIVOS (Device) $329.51
- BIOTRONIK (Device) $316.16
- Morphabond ER (Drug) $305.81
- UBRELVY (Drug) $299.86
- XTAMPZA (Drug) $270.53
- QULIPTA (Drug) $248.01
- GENERAL THERAPIES (Device) $224.42
- TROKENDI XR (Drug) $208.85
- Spectra WaveWriter (Device) $201.51
- AIMOVIG (Biological) $190.20
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Anesthesiology Doctors in Raleigh
Gerald Maccioli, Md, MD
Anesthesiology — Payments: $329,678
Anesthesiology $329,678
Dr. Marc Yelle, Md Phd, MD PHD
Anesthesiology — Payments: $33,152
Anesthesiology $33,152
Dr. Jack Lam, Md, MD
Anesthesiology — Payments: $7,948
Anesthesiology $7,948
Dr. Kevin Vorenkamp, M.d, M.D
Anesthesiology — Payments: $3,297
Anesthesiology $3,297
Robert Jacobson, Md, MD
Anesthesiology — Payments: $2,232
Anesthesiology $2,232
Duran Mitchell, M.d, M.D
Anesthesiology — Payments: $2,029
Anesthesiology $2,029